Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of P218 in Healthy Volunteers
NCT02885506Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Aug 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of P218 in malaria (10 arms), sponsored by Medicines for Malaria Venture. Primary endpoint: Incidence, Severity and Relationship to the Investigational Product of Observed and Self-reported Adverse Events at 11 days. Started Aug 2016; status: completed.
02
Drugs
P218
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02885506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02885506.